By Fineline Cube The National Medical Products Administration (NMPA) has approved Chinabridge (Shenzhen) Medical Technology Co., Ltd’s extracorporeal cardiopulmonary support auxiliary equipment and disposable membrane oxygenator bag for emergency use. The combination is designed for adult patients with acute respiratory failure or acute cardiopulmonary failure, whose symptoms are difficult to control with other treatment methods and have a predictable risk of continuous deterioration or death.
Indications and Use
The approved ECMO (Extracorporeal Membrane Oxygenation) system is a critical piece of salvage treatment equipment for patients with severe COVID-19 who have not responded to conventional treatments. ECMO is included in the “COVID-19 Diagnosis and Treatment Plans,” highlighting its importance in managing severe cases of the disease. The equipment provides life-saving support by temporarily taking over the function of the heart and lungs, allowing these organs to rest and recover.
Future Outlook
The approval of Chinabridge’s ECMO system underscores the ongoing efforts to enhance treatment options for patients with severe respiratory and cardiopulmonary conditions. By providing an effective and reliable solution for emergency use, Chinabridge aims to improve patient outcomes and contribute to the management of critical cases, particularly in the context of the COVID-19 pandemic. The company’s commitment to advancing medical technology highlights its dedication to addressing significant unmet needs in healthcare.-Fineline Info & Tech